NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Vincenzo Voi
Università degli Studi di Torino - Torino / Italy
Others
AD Scientific Index ID: 5642739
University of Turin
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Vincenzo Voi's MOST POPULAR ARTICLES
1-)
A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemiaR Galanello, A Kattamis, A Piga, R Fischer, G Leoni, V Ladis, V Voi, ...Haematologica 91 (9), 1241-1243, 2006992006
2-)
Current challenges in the management of patients with sickle cell disease–A report of the Italian experienceG Russo, L De Franceschi, R Colombatti, P Rigano, S Perrotta, V Voi, ...Orphanet Journal of Rare Diseases 14, 1-9, 2019542019
3-)
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trialAT Taher, MD Cappellini, A Kattamis, E Voskaridou, S Perrotta, AG Piga, ...The Lancet Haematology 9 (10), e733-e744, 2022362022
4-)
Late Effects of Bone Marrow Transplantation for ThalassemiaaA Piga, F Longo, V Voi, S Facello, R Miniero, B DresowAnnals of the New York Academy of Sciences 850 (1), 294-299, 1998261998
5-)
Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infectionF Longo, B Gianesin, V Voi, I Motta, VM Pinto, A Piolatto, A Spasiano, ...American Journal of Hematology 97 (2), E75-E78, 2022132022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept